Preclinical safety evaluation of levonadifloxacin, a novel anti-methicillin-resistant Staphyloccocus aureus benzoquinolizine fluoroquinolone by intravenous and oral administration.

导出 LinkOut

翻译打印收藏纠错

作者： Manohar,Nandanwar ^[1] ; Atul,Kansagara ^[1] ; Sangita,Gupta ^[1] ; Anasuya,Patel ^[1] ; Muftedar Ahmed,Patel ^[1] ; Ravindra,Yeole ^[1] ; Deepak,Thorve ^[1] ; Mahesh,Patel ^[1]

作者单位： Wockhardt Research Centre, Aurangabad, India. ^[1]

关键词 cardiovascular central nervous system chondrotoxicity fluoroquinolones genotoxicity phototoxicity repeat-dose toxicity

主题词投药, 口服(Administration, Oral);动物(Animals);抗菌药(Anti-Bacterial Agents);狗(Dogs);荧光喹诺酮类(Fluoroquinolones);人类(Humans);小鼠(Mice);喹嗪类(Quinolizines);喹诺酮类(Quinolones);大鼠(Rats)

DOI 10.1002/jat.4300

PMID 35146781

发布时间 2023-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of applied toxicology

2022年42卷8期

1354-1370页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Preclinical safety evaluation of levonadifloxacin, a novel anti-methicillin-resistant Staphyloccocus aureus benzoquinolizine fluoroquinolone by intravenous and oral administration.

Journal of applied toxicology

相似文献

Journal of applied toxicology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Preclinical safety evaluation of levonadifloxacin, a novel anti-methicillin-resistant Staphyloccocus aureus benzoquinolizine fluoroquinolone by intravenous and oral administration.

Journal of applied toxicology

相似文献

Journal of applied toxicology

相关期刊

检索历史清除